, , ,

<<


 >>  ()
Pages:     | 1 |   ...   | 5 | 6 ||

...

-- [ 7 ] --

163. , .., , .., , .., , .. - 2 - // VIII . ., 2001. 624 .

164. : , - 20082009 . M., 2010. 119 .

165. , .., , .., , .. // , , . 2005. . 4. 2. . 3437.

166. , .., , .. // / . .., .. .: . 1999. . 445447.

167. , .., , .., , .., , .. / .

., 2007. . 432434.

168. , .., , .., , ..

- // VI . ., 2004. . 494495.

169. , .., , .., , .., , .. // 9- . ., 2007. . 525526.

170. , .., , .., , .., , .. // . 2006. . 8. 23. 291 .

171. , .., , .., , .., , .., , .. - / . . . 2004. . 134135.

172. , .., , .., , .. // , , . 2004. . 3. 1. . 2629.

173. , .., , .., , .., , .. // . ., 2005. . 555 556.

174. , .., , .. , ..

// VII . ., 2000. 339 .

175. , .., , .., , .., , .., , .. // , , . 2011. 6. . 812.

176. , .., , .., , .. - .: -, 2005. 208 .

177. , .., , .., , .. . . .: , 1997. 224 .

178. , .. // . . . . ., 1989.

179. , .., , .. // 5:2832, 1999.

180. , .., , .. // . . 2(2): 6, 7 ( 5), 2001.

181. , .., , .. // . 1996. 6. . 49.

182. , .., , .., , .. . : . ., 2009. . 314316.

183. , .. . Consilium medicum 1999;

1: 518.

184. , .. . - . , . 1995;

3: 18 22.

185. , .., , .., , .. . ., 2004. 384 .

186. , .., , .., , .., , ..

. : , 2002;

1267.

187. , .. - , // . . . . , 2003.

140 .

188. , .., , .. / . . 1997. . 2. . 38.

189. , .., , .. // -. 2006. 1. . 3638.

190. , .., , .., , .. // . . 2004. 6. . 5456.

191. , .., , .. . .: , 2000. 172 .

192. , .. / . 1997. 5. . 714.

193. Adimora, . Treatment of uncomplicated genital Chlamydia trachomatis infections in adults. Clin Infect Dis. 2002. Oct 15;

35 (Suppl 2):S1836.

194. Allavena, P., Paganin, C., Zhou, D. Interleukine-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium / Blood. 1994. Vol. 84, 7. P. 2261.

195. Alnemri, E. Mammalian cell death proteases A family of highly conserved aspartate specific cystem proteases / J. Cell. Blochem. 1997. Vol. 64. 1. P. 3342.

196. Arany, I., Turyng, S. Status of local cellular immunity in interferon responsive and nonresponsive human papillomavirus-associated lesions / Sex. Transm. Dis. 1996. Vol. 23. 6. P. 475480.

197. Armant, M., Delespesse, G., Sarfati, M. IL-2 and IL-7 but not IL- protect natural killer cells from death by apoptosis and up-regulate bcl- expression / Immunology. 1995. Vol. 85, 2. P. 33137.

198. Armstrong, D., Maw, R., Dinsmore, W. Combined therapy trial with interferon alpha-2a and ablative therapy in the treatment of anogenital warts / Belfast Genitourens Med. 1996. Vol. 72, 2. P. 103107.

199. Baker, D.A., Blythe, J.G. Once-daily valaciclovir hydrochlorid for suppression of recurrent genital herpes. Obstet Gynecol., 1999.

200. Bas, S., Genevay, S., Schenkel, .. et al. Importance of species-specific antigens in the serodiagnosis of Chlamydia trachomatis reactive arthritis.

Rheumatology (Oxford). 2002 S;

41(9):101720.

201. Belau, T., Eko, F.O., Ananaba, G.A. et al. Chemokine and chemokine receptor dinamics during genital chlamydial infection. Infect Immun., Feb;

70(2):84450.

202. Bhalla, P., Kaushika, A. Cervical cytology in women with bacterial vaginosis / J. Pathol. Microbiol. 1998. Vol. 41, 3. P. 271275.

203. Black, C.M., Marrazzo, J., Johnson, R.E. et al. d-t-head multicenter comparison of DNA probe and nucleic acid amplification tests for Chlamydia trachomatis infection in women performed with an improved reference standard. J Clin Microbial., 2002 Oct;

40(10):375763.

204. Blocker, .., Krysiak, R.G., Behets, F. et al. Quantification of Chlamydia trachomatis Elementary Bodies in Urine by Ligase Chain Reaction. J Clin Microbiol.2002 Oct;

40(10):36314.

205. Bollen, L. Human papillomavirus DNA after treatment of cervical dysplasia : low prevalence in normal cytologic smears / L. Bollen, S. Tjong A-Hung, J. Van der Velden // Cancer. 1996. Vol. 77. 12. P. 2538 2543.

206. Bosch, F.X., Qiao, Y-L., Castellsague, X. The epidemiology of human papillomavirus infection and its association with cervical cancer. Int J Gynecol Obstet 2010;

94 (Suppl 1):S8S21.

207. Brisson, J. Determinate of persistent detection of human papillomavirus DNA in the uterine cervix / J. Brisson, I. Bairati, C. Morin // J. Infect. Dis.

1996. Vol. 173, 4. P. 794799.

208. Brown, W.J., Skeiky, Y.A., Probst P. et al. Chlamydial antigens colocalize within IncA-laden fibers extending from the inclusion membrane into the host cytosol. Infect Immun., 2002 Oct;

70(10):58604.

209. Bulas, D.I., Ahlstrom, P.A., Sivit, C.J., Blask, A.R., O-Donnell R.M. Pelvic inflammatory disease in the adolescent: comparison of transabdominal and transvaginal sonographic evaluation. Radiology 1992. V 83. N 2. P. 435439.

210. Butz, K. Virusinfektion und tumorentstehung / K. Butz, A. Ullmann, F. Hoppe-Seyler // MTA. 1997. Vol. 12. P. 878880.

211. Castriciano, S., Luinstra, ., Jang, D. et.al. Accuracy of results obtained by performing second ligase chain reaction assay and PCR analysis on urine samples with positive or near-cutoff results in the LCx test for Chlamydia trachomatis. J Clin Microbiol., 2002 Jul;

40(7):26324.

212. Catalano, G.F., Muzii, L., Marana, R. Tubal factor infertility. Rays, 1998.

V 23. N4. P. 673682.

213. Cates, W.Jr., Joesoef, M.R., Goldman, M.V. Atypical pelvic inflammatory disease: can we identify clinical predictors? // Am. J. Obstet. Gynecol., 1993. Vol. 169. . 341346.

214. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2006. Morb Mortal Wkly Rep 2006;

55(RR-11):3549.

215. Chang Foreman, H.-C., Van Scoy, S., Cheng, T.-F., Reich, N.C.

Activation of interferon regulatory factor 5 by site specific phosphorylation.

PLoS ONE 2012;

7 (3): Art e33098. doi:10.1371.

216. Chernesky, M.A. Chlamydia trachomatis diagnostics. Sex Transm Infect.

2002 Aug;

78(4):2324.

217. Chlamydia trachomatis infections in young women: Further uncovering the hidden epidemic. Arch Pediatr Adolesc Med, 2007;

161:246251.

218. Claeys, P., Gonzalez, ., Gonzalez, . et al. Prevalence and risk factors of sexually transmitted infections and cervical neoplasia in women' s. Sex Transm Infect., 2002 Jun;

78(3):2047.

219. Colli, E. Treatment of male partners and recurrence of bactenal vaginosis a randomised trial / E. Colli, M. Landoni, F. Parazzini // Genitounn Med. 1997. Vol. 73. 4. P. 267270.

220. Coonrod, D.V. Chlamydial infections. Curr Womens Health Rep., Aug;

2(4):26675.

221. Corey, L. Current standards of management of genital herpes. World STD/AIDS Congress. Singapore, 1995;

11.

222. Corey, L. Recommendations from the IHMF Management Strategies Workshop. France,1997.

223. Critchlow, C. Determinants of cervical ectopia and of cerwicitis age, oral contraception, specific cervical infection, smoking and douching / C. Critchlow, P. Wolner-Hanssen, D. Eschenbach // Am. J. Obst. Gynecol.

1995. Vol. 173. 2. P. 534543.

224. Dellinger, R.P. Current Therapy for sepsis // Infect. Dis. Clin. N. Am. 1999. Vol. 13. P. 495509.

225. Donati, ., llini, G.M., Sparacino, . et al. Comparative in vitro activity of garenoxacin against Chlamydia spp. J. Antimicrob Chemother, 2002;

Sep;

50(3):40710.

226. Ehgh, V. Human papillomavirus and cervical intraepithelial neoplasia grade 2 and 3 correlation between cytohistomorphological findings and PCR-analysis / V. Ehgh, A. Sauer, A. Olsen // Acta Cytol., 1996. Vol. 40, 4. P. 804.

227. Eisner, P. Vulvovaginitis, Varcel Dekker / P. Eisner, J. Martius. Basel, 1998. 20 p.

228. Ferenczy, A. Epidemiology and clinical pathophysiology of condylomata acuminata / A. Ferenczy // Am. J. Obst. Gynecol., 1995. Vol. 172. 4.

P. 13311339.

229. Ferenczy, A. Genital Infections Neoplasia Update, 1998;

(Juli,l): 123.

230. Finan, R.R. Tamim, H., Almawi, W.Y. Identification of Chlamydia trachomatis DNA in human papillomavirus (HPV) positive women with normal and abnormal cytology. Arch Gynecol Obstet., 2002;

Jul;

266(3):168175.

231. Fitzgerald, K.A. NLR-containing inflammasomes: Central mediators of host defense and inflammation. Eur J. Immunol., 2010;

40 (3): 595598.

doi: 10.1002/eji.201040331.

232. Frazer, I.H. HPV vaccines. Int J Gynecol Obstet, 2006;

94 (Suppl 1):S81 S88.

233. Friedman-Kien, A. Management of condylomata acuminata with Alferon N infection, interferon alpha-n3 (human leucocyte derived) / A. FriedmanKien // Am. J. Obstetr. Gynecol., 1995. Vol. 172, 4. P. 13591368.

234. Gall, S. Human papillomavirus infection and therapy with interferon / J.

Obstetr. Gynecol. 1995. Vol. 172. 4. P. 13541359.

235. Gerard, .., Wang, Z., Whittum-Hudson, J.A. et all. Cytokine and chemokine mRNA produced in synovial tissue chronically infected with Chlamydia trachomatis and . pneumoniae. J. Rheumatol. S;

29(9):182735.

236. Godinjak, Z., Idrizbegovi, E. Should be diagnostic hysteroscopy a routine procedure during diagnostic laparoscopy in infertile women? Bosn J Basic Med Sci 2008;

8: 4447.

237. Goldie, S. A public health approach to cervical cancer control:

Considerations of screening and vaccination strategies. Int J Gynecol Obstet 2011;

94 (Suppl 1):S95S105.

238. Halioua, B. Epidemiology of genital herpesrecent advances / B. Halioua, J. Malkin // Eur. J. Dermatol., 1999. Vol. 9, 3. P. 177184.

239. Hannelore, M.,Gtz, Reinier, J.M., Bom, Mireille, E.G., Wolfers, Johan, Ingrid, V.F. van den Broek, Arjen, G.CL., Speknijder, Sylvia, M., Bruisten.

Use of Chlamydia trachomatis-resolution typing: an extended case study to distinguish recurrent or persistent infection from newinfection Sex Transm Infect doi:10.1136/sextrans-2013051218.

240. Hatch, K.D., Ngan, H.Y.S., Trimble, C.L. Clinical manifestations of HPV infection. Section A: Benign manifestations of HPV infection. Int J Gynecol Obstet, 2006;

94 (Suppl 1):S32S49.

241. Henry-Suchet, J. PID clinical and laparoscopic aspects. Ann. NY Acad.

Sci. 2000. 9000:3018.

242. Honey, E., Templeton, A. Prevention of pelvic inflammatory disease by the control of the C. Trachomatis infection.Int.J.Gynaecol. Obstetric., Sep;

78(3):257.

243. Hung, ., Ng, ., Ngai, C.S., , P.C. Chlamydia trachomatis in infertile women undergoing uterine instrumentation: Screen or treat. Hum Reprod.

2002 Aug;

17(8):22156.

244. Igarashi, T., Konno, R., Okamoto, S. t al. Involvement of granule mediated apoptosis in the cyclic changes of normal human endometrium // Tohoku J. Exp. Med., 2001. Vol. 193, 1. . 1325.

245. International Agency for Research n nr. Histopathology and Cytopathology of the Uterine Cervix: Digital Atlas. Frappart L, Fontaniere ., Lucas ., Sankaranarayanan R., eds. December 2010,IARC nr Base No. 8.

246. Jones, R.W., Rowan, D.M., Stewart, A.W. Vulvar Intraepithelial Neoplasia: aspects of the natural history and outcome in 405 women. Obstet Gynecol 2009;

106(6):131926.

247. Joo, S.H., Kim, M.J., Lim, J.S., Kim, J.H., Kim, K.W. CT diagnosis of Fitz-Hugh and Curtis syndrome: value of the arterial phase scan. Korean J Radiol 2007;

8:4047.

248. Kaufman, R.H. t al. Am J Obstet Gynecol 1997;

176(1,pt/l):8792.

249. Kinnunen, .., Molander, P., Paavonen, J. et al.Chlamydial heat shock protein 60-specific t-cells in inflamed salpingeal tissue.Fertil Steril, Jan;

77(1):1626.

250. Kinnunen, .., Surcel, H.M., Paavonen, J. HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomatis related tubal factor infertility: s-control study. Hum Reprod. 2002 Aug;

17(8):20738.

251. Kruger, T. Induction of neutrophil chemoattractant cytokines by Mycoplasma hominis in alveolar type 2 cells / T. Kruger, J. Baer // Infect.


Imunn. 1997. Vol. 65, 12. P. 51315136.

252. Land, J.A. Chlamydia trachomatis in infertile women undergoing uterine instrumentation:Screen or treat. Hum Reprod, 2002 Aug;

17(8):2216.

253. Land, S., Tabrizi, S., Gust, ., Johnson, . et al. External quality assessment program for Chlamydia trachomatis diagnostic testing by nucleic acid amplification assays. J Clin Microbial. 2002 Aug;

40(8):2893 6.

254. Land, S., Tabrizi, S., Gust, ., Johnson, . et al. External quality assessment program for Chlamydia trachomatis diagnostic testing by nucleic acid amplification assays. J Clin. Microbial. 2002 Aug;

40(8):2893 6.

255. Li, H., Liang, Z. Determination of tumor necrosis factor-alpha and interleukin-6 levels of the tubal fluids in patients with infertiliti caused by infection of chlamydia trachomatis. Zhonghua Fu Chan Ke Za Zhi, Jun;

35(7):4112.Chinese.

256. Loomis, W.P., Starnbach, M.N. T-cell responses to chlamydia trachomatis. Curr. Opin. Microbiol.2002 Feb;

5(1):8791.Reviev.

257. Low, N., Cowan, F. Genital chlamydial infection. Clin. Evid. 2002 Jun;

(7):140915.

258. Malinovskaya, V.V., Strizhakov, A.N., Kagramanova, J.A., Soloviova, M.N. Recombinant Interferon-2b (Viferon-gel) in treatment of herpes simplex infection / 3-rd Joint Meeting of the ICS and the ISICR. / European Cytokine Network, 2000. V. 11190.

259. Malinovskaya, V.V., Strizhakov, A.N., Solovyova, M.N.

Kagramanova, J.A. Viferon-gel in Complex Treatment of recurrent Genital Herpes / Antiinfective Drugs and Chemotherapy. V.17. 1. 2000. Biennial Conference on Antiinfective Agents and Chemotherapy. Munich, p. 82.

260. Malotte, C.K., Ledsky, R., Hogben, M. et al. Comparison of methods to increase repeat testing in persons treated for gonorrhea and or chlamydia at public sexually transmitted disease clinics. Sex Transm Dis 2004;

31:637 642.

261. zz, J.M., Handsfield, .., Whittington, W.L. Predicting chlamydial and gonococl cervical infection: implications for management of cervicitis. Obstet Gynecol. 2002 Sep;

100(3):57984.

262. Mazzoli, S., Ospendale, S. Immune response of the genital tract to Chlamydia trachomatis / Abstr. 6th Congr. EADV. Dublin, 1997. P. 28.

263. McKenna D.B., Neill, W.A., Norval, M. Herpes simplex virus-specific immune responses in subjects with frequent and infrequent orofacial recrudescences. Brit J. dermatol. 2001;

144: 45964.

264. Meylan, P., Wietlisbach, V., Buenzli, D., Sahli, R. Protection against HSV 2 infection by HSV-1: a population-based transversal study. ClinMicrobiol Infect., 2003;

9(1):53.

265. Miller, R.L., Tomai, M.A., Harrison, C.J., Bernstein, D.I.

Immunomodulation as a treatment strategy for Genital herpes: review of the evidence. International immunopharmacology. 2002;

2 (4): 44351.

266. Newman, L.M., Warner, L., Weinstock, H.S. Predicting subsequent infection in patients attending sexually transmitted disease clin-ics. Sex Transm Dis 2006;

33:737742.

267. Niccolai, L.M., Hochberg, A.L., Ethier, K.A. et al. Burden of recurrent.

268. Paler, Rj.Jr., Simpson, D.R., ye, A.M. et al. The relationship of inflammation in the Papanicolaou smear to Chlamydia trachomatis infection in high-risk population. Contraception. 2000, Mar;

61(3):2314.


269. Paraskevaidis E., Arbyn M., Sotiriadis A. et al. The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature. Cancer Treat Rev 2004;

30:20511.

270. Peretti, S., Shaw, A., Blanchard, J., Bohm, R., Morrow, G., Lifson, J.D., Gettie, A., and Pope, M. Immunomodulatory effects of HSV-2 infection on immature macaque dendritic cells modify innate and adaptive responses// Blood. 2005. Vol. 106. 4. . 13051313.

271. Polesko, I.V., Khaldin, A.A., Malinovskaya, V.V., Butov, Y.S. 3-rd Joint Meeting of ICS/1SICR. Amsterdam, 2000. P. 193.

272. Rastogi, S., Das, B., Mittal, A. Serum IgM to Chlamydia trachomatis in pregnansy:its usefulness for screening. Br J Biomed Sci. 2002;

59(1):304.

273. Reitano, M., Tyring, S., Lang, W. Valaciclovir for the suppression of recurrent genital herpes infection: a large-scale dose range-finding study.

J Infec Dis 1998;

178: 60310.

274. Rockey, D.D., Viratyosin, W., Bannantine, J.P. et al. Diversity within inc genes of clinical Chlamydia trachomatis variant isolates that occupy nn fusogeni inclusions. Microbiology, 2002 Aug;

148(Pt 8):2497505.

275. Rodel, J., Vogelsang, ., Prager, . et al. Role of Interferon-Stimulated Gene Factor gamma and Beta Interferon in HLA Class 1 Enhancement in synovial fibroblasts upon Infection with Chlamydia trachomatis. Infect.

Immun., 2002 Nov;

70(11):61406.

276. Shaw, A.C., Larsen, M.R., Roepstorff, . et al. Identification and characterization of novel Chlamydia trachomatis reticulate body protein.

FEMS Microbiol Lett. 2002 Jul 2;

212(2):193202.

277. Singh, R., Kumar, A., Creery, W.D., Ruben, M., Giulivi, A., and Diaz Mitoma, F. Dysregulated expression of IFN- and IL-10 and impaired IFN -mediated responses at different disease stages in patients with genital herpes simplex virus-2 infection//Clin.Exp.Immunol. 2003. Vol. 133. 1. . 97107.

278. Solomon, D., Davey, D., Kurman, R., Moriarty, ., 'nnr, D., r, . et al. Forum Group Members;

Bethesda 2001 Workshop. The Bethesda System: terminology for reporting results of cervical cytology.

JAA 2002;

287(16):21149.

279. Strand, A. Long-term suppressive therapy for genital herpes in the immunocompetent host. Herpes 1999;

6: 257.

280. Strizhakov, A.N., Malinovskaya, V.V., Kagramanova, J.A. Disturbances of Interferonal Status and its Correction by Viferon in Patients With Acute Tube-ovarian Inflammatory Diseases. XVI FIGO World Congress of Gynecology and Obstetrics. 2000. Washington D.C. . 102.

281. Suzuki, T., Sasano, H., Takaya, R. et al. Leukocytes in normal cyclinc Human ovaries: immunohistochemical distribution and characterization. // Hum. Reprod., 1998. Vol. 13. 8. P. 186191.

282. Suzuki, T., Sasano, H., Takaya, R. et al. Leukocytes in normal cyclinc Human ovaries:immunohistochemical distribution and characterization. // Hum. Reprod., 1998. Vol. 13. 8. P. 186191.

283. Sweet, R. New approaches for the treatment of bacterial vaginosis / R. Sweet // Am. J. Obst. Gynecol. 1993. Vol. 169, 20. P. 479482.

284. Tmim, ., Finan, R.R., Sharida, .. et al. Cervicovaginal coinfections with human papillomavirus and Chlamydia trachomatis. Diagn Microbiol Infect Dis. 2002 Aug;

43(4):27781.

285. Villa, L.L., Denny, L. Methods for detection of HPV infection and its clinical utility. Int J Gynecol Obstet 2006;

94 (Suppl 1):S71S80.

286. Villa, L.L. Biology of genital human papillomaviruses. Int J Gynecol Obstet 2006;

94 (Suppl 1):S3S7.

287. Wald, A., Warren, T. Suppression of subclinical shedding of HSV type with valaciclovir. American Society for Microbiology, USA, 1998: Abstr H-82.

288. Wardowska, A., Dzierzbicka, K., Szaryska, M. et al. Analogues of muramyl dipeptide (MDP) and tuftsin limit infection and inflammation in murine model of sepsis. Vaccine 2009;

27 (3):369374. doi:

10.1016/j.vaccine.2008.11.017.

289. Whitley, R.J. Optimizing the management of genital herpes. Ed. Royal Society of Medicine.Ltd.2000;

247.

290. Wiesenfeld, H.C., Heine, R.P., Krohn, .. et al. Association between elevated neutrophil defensin levels and endometritis. J Infect Dis. 2002 S 15;

186(6):7927.

291. Wiesenfeld, H.C., Hillier, S.L., Sweet, R.L. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease.

Obstet Gynecol. 2002 S;

100(3):45663.

292. Witkin, S.S. Linhares, I.. Chlamydia trachomatis in subfertile women undergoing uterine instrumentation: an alternative to direct microbial testing or prophylactic antibiotic treatment. Hum Reprod. 2002 Aug;

17(8):1938 41.

293. Wright, .. Jr. Pathology of V infection at the cytologic and histologic levels: Basis for a 2-tiered morphologic classification system. Int J Gynecol Obstet 2009;

94 (Suppl 1):S22S31.

294. Wuttke et al., Pitzel, L., Knokei et al. Immune-endocrine interactions affecting luteal function in pigs // J. Reprod. Fertil. Suppl., 1997. Vol. 55.

P. 1929.

295. Wuttke et al., Pitzel, L., Knokei et al. Immune-endocrine interactions affecting luteal function in pigs//J. Reprod. Fertil. Suppl., 1997. Vol. 55. P. 1929.

296. Yeaman, G.R., Collins, J.E., Fanger, M.W., Wira, C.R. CD8+ T-cells in human uterine endometrial lymphoid aggregates:evidence for accumulation of cells by traficking // Immunology, 2001. Vol. 102. 4. P. 434 440.

297. Yeaman, G.R., Collins, J.E., Fanger, M.W., Wira, C.R. CD8+ T-cells in human uterine endometrial lymphoid aggregates:evidence for accumulation of cells by traficking // Immunology, 2001. Vol. 102, 4. P. 434440.

298. Yeaman, G.R., Guyere, P.M., Fanger, M.V. et al. Unique CD8+ T cell-rich limphoid aggregates in human uterine endometrium // J. Leukoc. Biol., 1997. Vol. 61. 4. P. 427435.

299. Yeaman, G.R., Guyere, P.M.,Fanger, M.V. et al. Unique CD8+ T cell-rich limphoid aggregates in human uterine endometrium//J. Leukoc. Biol.1997.

Vol. 61. 4. P. 427435.

300. Yee, A. Chlamydia trachomatis screening in family planning clinic / A. Yee, K. Twombly-al-Hallong // Fam. Pract. Res. J., 1993. Vol. 13. 14. P. 365372.

301. Zhou, B., Corg, L., Sha, Y. Pathogens of transmitted disease in the pathogenesis of acute pelvic inflammatory disease. Zhonghua Fu Chan Ke Za Zhi, 2001;

Sep;

36(9):53941.Chinese.



Pages:     | 1 |   ...   | 5 | 6 ||
 
 >>  ()





 
<<     |    
2013 www.libed.ru - -

, .
, , , , 1-2 .